» Articles » PMID: 9727886

Global Burden of Diabetes, 1995-2025: Prevalence, Numerical Estimates, and Projections

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 1998 Sep 4
PMID 9727886
Citations 1190
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To estimate the prevalence of diabetes and the number of people with diabetes who are > or =20 years of age in all countries of the world for three points in time, i.e., the years 1995, 2000, and 2025, and to calculate additional parameters, such as sex ratio, urban-rural ratio, and the age structure of the diabetic population.

Research Design And Methods: Age-specific diabetes prevalence estimates were applied to United Nations population estimates and projections for the number of adults aged > or =20 years in all countries of the world. For developing countries, urban and rural populations were considered separately

Results: Prevalence of diabetes in adults worldwide was estimated to be 4.0% in 1995 and to rise to 5.4% by the year 2025. It is higher in developed than in developing countries. The number of adults with diabetes in the world will rise from 135 million in 1995 to 300 million in the year 2025. The major part of this numerical increase will occur in developing countries. There will be a 42% increase, from 51 to 72 million, in the developed countries and a 170% increase, from 84 to 228 million, in the developing countries. Thus, by the year 2025, >75% of people with diabetes will reside in developing countries, as compared with 62% in 1995. The countries with the largest number of people with diabetes are, and will be in the year 2025, India, China, and the U.S. In developing countries, the majority of people with diabetes are in the age range of 45-64 years. In the developed countries, the majority of people with diabetes are aged > or =65 years. This pattern will be accentuated by the year 2025. There are more women than men with diabetes, especially in developed countries. In the future, diabetes will be increasingly concentrated in urban areas.

Conclusions: This report supports earlier predictions of the epidemic nature of diabetes in the world during the first quarter of the 21st century. It also provides a provisional picture of the characteristics of the epidemic. Worldwide surveillance of diabetes is a necessary first step toward its prevention and control, which is now recognized as an urgent priority.

Citing Articles

Effectiveness of Roux-en-Y Gastric Bypass in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials.

Wang Y, Pan Y, Xiao Y, Yang J, Wu H, Chen Y Obes Surg. 2025; 35(3):1109-1122.

PMID: 39891839 DOI: 10.1007/s11695-025-07698-8.


Delayed Immune Response Upon Injury in Diabetic Wounds Impedes Healing.

Dhanraj P, Boodhoo K, van de Vyver M Immun Inflamm Dis. 2025; 13(2):e70142.

PMID: 39891428 PMC: 11786017. DOI: 10.1002/iid3.70142.


Differentiation, reduction, and proliferation of pancreatic β-cells and their regulatory factors.

Inada A Diabetol Int. 2025; 16(1):23-29.

PMID: 39877437 PMC: 11769892. DOI: 10.1007/s13340-024-00774-x.


Changes in Cardiovascular Health at Midlife and Subsequent Cardiovascular Outcomes in Individuals With Diabetes.

Sattler E, Lassale C, Diaw M, Joseph J, Singh G, Samb A JACC Adv. 2025; 4(1):101450.

PMID: 39801817 PMC: 11719311. DOI: 10.1016/j.jacadv.2024.101450.


Unveiling nature's antidiabetic potential in Berberis orthobotrys seeds for alloxan-induced diabetic rats.

Abid A, Muzammel H, Javed M, Iqbal M, Mahmood S, Zidan A Sci Rep. 2025; 15(1):746.

PMID: 39755734 PMC: 11700095. DOI: 10.1038/s41598-024-83987-z.